Paper5777345
Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.
Kok P and 1 other. Biochemistry, 1969. Cited by 101 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Papers, record 5777345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5777345
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolytic Agents | Major topic |
| Plasminogen | Major topic |
| Animals | |
| Chromatography, Gel | |
| Electrophoresis | |
| Female | |
| Methods | |
| Molecular Weight | |
| Ovary | |
| Pregnancy | |
| Serum Albumin, Bovine | |
| Swine |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,199,539 | Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199539 | PubMed |
| 6,681,615 | Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6681615 | PubMed |
| 6,430,612 | Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6430612 | PubMed |
| 6,208,894 | Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator. | Biochem J | 1984 | https://conductscience.org/library/papers/6208894 | PubMed |
| 5,822,582 | Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. | J Clin Invest | 1969 | https://conductscience.org/library/papers/5822582 | PubMed |
| 4,282,470 | Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. | Biochem J | 1974 | https://conductscience.org/library/papers/4282470 | PubMed |
| 405,241 | Some characteristics of urokinase released in organ culture of human kidney. | Experientia | 1977 | https://conductscience.org/library/papers/405241 | PubMed |
| 26,336 | Purification of plasminogen activators from human seminal plasma. | Biochem J | 1978 | https://conductscience.org/library/papers/26336 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLAT | 5,327 | PubTator's text mining | https://conductscience.org/library/genes/5327 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5777345
GET https://conductscience.org/api/papers/v1/5777345/authors